          
|
|
New
Directions at the College of Pharmacy
Once
an afterthought to insurers and employers, rapidly rising prescription
drug costs have managed care administrators scrambling for answers.
Drivenby consumer anger, members of Congress have introduced bill
after bill to address the problem, underscoring the growing political
potency of this issue.
Conversely, the Pharmaceutical Research and Manufacturers Association
claims that it costs pharmaceutical firms $500 million to get a drug
through the screening process, into the development pipeline, clinically
tested, and to market. And for all that effort and money, only three
in 10 new drugs make a profit or break even.
The following two initiatives, begun since summer 1999, have placed
the College
of Pharmacy right in the thick of the national drug debate.
|